145 related articles for article (PubMed ID: 10916719)
1. Autonomic nervous function in de novo parkinsonian patients in basal condition and after acute levodopa administration.
Quadri R; Comino I; Scarzella L; Cacioli P; Zanone MM; Pipieri A; Bergamasco B; Chiandussi L
Funct Neurol; 2000; 15(2):81-6. PubMed ID: 10916719
[TBL] [Abstract][Full Text] [Related]
2. Orthostatic hypotension in de novo Parkinson disease.
Bonuccelli U; Lucetti C; Del Dotto P; Ceravolo R; Gambaccini G; Bernardini S; Rossi G; Piaggesi A
Arch Neurol; 2003 Oct; 60(10):1400-4. PubMed ID: 14568810
[TBL] [Abstract][Full Text] [Related]
3. Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and of, autonomic dysfunction.
Holmberg B; Corneliusson O; Elam M
Mov Disord; 2005 Aug; 20(8):976-81. PubMed ID: 15858814
[TBL] [Abstract][Full Text] [Related]
4. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy.
Bouhaddi M; Vuillier F; Fortrat JO; Cappelle S; Henriet MT; Rumbach L; Regnard J
Auton Neurosci; 2004 Nov; 116(1-2):30-8. PubMed ID: 15556835
[TBL] [Abstract][Full Text] [Related]
5. Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects.
Micieli G; Martignoni E; Cavallini A; Pacchetti C; Rossi F; Horowski R; Nappi G
Funct Neurol; 1996; 11(6):317-25. PubMed ID: 9074912
[TBL] [Abstract][Full Text] [Related]
6. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
[TBL] [Abstract][Full Text] [Related]
7. The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patients.
Stryjer R; Klein C; Treves TA; Rabey JM
Acta Neurol Scand; 2005 Feb; 111(2):89-94. PubMed ID: 15644067
[TBL] [Abstract][Full Text] [Related]
8. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ
Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.
Lucetti C; Gambaccini G; Del Dotto P; Ceravolo R; Logi C; Rossi G; Murri L; Bonuccelli U
Parkinsonism Relat Disord; 2006 Jun; 12(5):279-83. PubMed ID: 16549382
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Teychenne PF; Bergsrud D; Elton RL; Racy A
Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
[TBL] [Abstract][Full Text] [Related]
11. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
12. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
Koziorowski D; Friedman A
Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
[TBL] [Abstract][Full Text] [Related]
13. [Relation between autonomic dysfunction and progression of Parkinson's disease].
Oka H; Mochio S; Inoue K
Rinsho Shinkeigaku; 2001 Jun; 41(6):283-8. PubMed ID: 11771156
[TBL] [Abstract][Full Text] [Related]
14. Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.
Muhlack S; Woitalla D; Welnic J; Twiehaus S; Przuntek H; Müller T
Neurosci Lett; 2004 Jun; 363(3):284-7. PubMed ID: 15182961
[TBL] [Abstract][Full Text] [Related]
15. Effect of a single dose of standard levodopa on cardiac autonomic function in Parkinson's disease.
Sriranjini SJ; Ganesan M; Datta K; Pal PK; Sathyaprabha TN
Neurol India; 2011; 59(5):659-63. PubMed ID: 22019646
[TBL] [Abstract][Full Text] [Related]
16. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
Reddy S; Factor SA; Molho ES; Feustel PJ
Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
[TBL] [Abstract][Full Text] [Related]
17. Orthostatic heart rate variability analysis in idiopathic Parkinson's disease.
Mihci E; Kardelen F; Dora B; Balkan S
Acta Neurol Scand; 2006 May; 113(5):288-93. PubMed ID: 16629763
[TBL] [Abstract][Full Text] [Related]
18. A paradoxical acute effect of levodopa in de novo parkinsonian patients: worsening of some bradykinetic components.
Pasetti C; Lualdi MM; Pinelli P
Neurol Sci; 2003 Oct; 24(3):201-2. PubMed ID: 14598087
[TBL] [Abstract][Full Text] [Related]
19. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test.
Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G
Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263
[TBL] [Abstract][Full Text] [Related]
20. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
